Insider Stock Trading History of Katkin Keith


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Katkin Keith since year 2005. The trader's CIK number is 1314596. At the time of this reporting, Katkin Keith is the President and CEO of Avanir Pharmaceuticals . (stock ticker symbol AVN). See this page for all insider trading activities at Avanir Pharmaceuticals .


Stock purchases, sales, and option exercises reported by insider Katkin Keith since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2014-12-15 AVNR Avanir Pharmaceuticals Option Ex 195,160 1.52 295,667
2014-12-15 AVNR Avanir Pharmaceuticals Sale 215,160 16.95 3,646,962
2014-12-17 AVNR Avanir Pharmaceuticals Sale 62,520 16.93 1,058,463
2014-10-24 AVNR Avanir Pharmaceuticals Sale 27,567 11.76 324,187
2014-08-01 AVNR Avanir Pharmaceuticals Sale 9,670 5.26 50,864
2014-05-28 AVNR Avanir Pharmaceuticals Sale 442,212 5.01 2,215,482
2013-12-18 AVNR Avanir Pharmaceuticals Sale 29,515 2.67 78,923
2013-11-01 AVNR Avanir Pharmaceuticals Sale 4,385 4.14 18,136
2013-08-02 AVNR Avanir Pharmaceuticals Sale 15,500 4.84 74,989
2013-05-15 AVNR Avanir Pharmaceuticals Option Ex 215,438 .70 151,883
2013-05-15 AVNR Avanir Pharmaceuticals Sale 250,438 3.26 816,427
2012-12-03 AVNR Avanir Pharmaceuticals Sale 18,250 2.55 46,464
2012-06-25 AVNR Avanir Pharmaceuticals Sale 190,125 3.50 664,867
2012-03-06 AVNR Avanir Pharmaceuticals Buy 10,000 2.61 26,090
2011-12-02 AVNR Avanir Pharmaceuticals Sale 17,495 2.37 41,428
2011-11-16 AVNR Avanir Pharmaceuticals Option Ex 109,013 .53 57,776
2011-11-17 AVNR Avanir Pharmaceuticals Option Ex 109,012 .70 76,853
2011-11-16 AVNR Avanir Pharmaceuticals Sale 109,013 2.59 282,343
2011-11-17 AVNR Avanir Pharmaceuticals Sale 109,012 2.59 282,668
2010-12-02 AVNR Avanir Pharmaceuticals Option Ex 195,300 .53 103,509
2010-12-02 AVNR Avanir Pharmaceuticals Sale 195,300 4.08 797,214
2010-11-01 AVNR Avanir Pharmaceuticals Sale 20,000 5.70 114,000
2010-09-01 AVNR Avanir Pharmaceuticals Sale 62,874 2.83 177,870
2010-08-31 AVNR Avanir Pharmaceuticals Sale 40,000 2.86 114,520
2010-05-03 AVNR Avanir Pharmaceuticals Sale 65,906 3.06 201,342
2010-04-30 AVNR Avanir Pharmaceuticals Sale 40,000 3.31 132,360
2010-04-08 AVNR Avanir Pharmaceuticals Sale 10,000 3.01 30,099
2010-03-29 AVNR Avanir Pharmaceuticals Sale 30,000 2.60 78,000
2010-01-04 AVNR Avanir Pharmaceuticals Sale 20,000 1.90 37,960
2010-01-05 AVNR Avanir Pharmaceuticals Sale 15,025 1.94 29,178
2009-12-15 AVNR Avanir Pharmaceuticals Sale 37,335 1.82 68,136
2009-02-24 AVNR Avanir Pharmaceuticals Buy 15,000 .44 6,525
2006-05-25 AVNR Avanir Pharmaceuticals Buy 2,500 8.99 22,475

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Katkin Keith (President and CEO of Avanir Pharmaceuticals at the time of this reporting) see the Securities and Exchange Commission (SEC) website.